Lista de obras -

A Multidisciplinary Approach to Fungal Infections: One-Year Experiences of a Center of Expertise in Mycology

artículo científico publicado en 2020

Cyclosporine A trough concentrations are associated with acute GvHD after non-myeloablative allogeneic hematopoietic cell transplantation

scientific article published on 21 March 2019

Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance

artículo científico publicado en 2020

Drug-interactions of azole antifungals with selected immunosuppressants in transplant patients: strategies for optimal management in clinical practice

artículo científico

Favorable outcome of neonatal cerebrospinal fluid shunt-associated Candida meningitis with caspofungin.

artículo científico publicado en 2013

Flucloxacillin Results in Suboptimal Plasma Voriconazole Concentrations.

artículo científico publicado en 2017

Impact of therapeutic drug monitoring of voriconazole in a pediatric population

artículo científico publicado en 2011

Implications for IV posaconazole dosing in the era of obesity

scientific article published on 01 April 2020

In reply to comment on ‘Therapeutic drug monitoring-guided treatment versus standard dosing of voriconazole for invasive aspergillosis in haematological patients: A multicentre, prospective, cluster randomised, crossover clinical trial’

artículo científico publicado en 2023

International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus.

artículo científico publicado en 2015

Isavuconazole susceptibility of clinical Aspergillus fumigatus isolates and feasibility of isavuconazole dose escalation to treat isolates with elevated MICs.

artículo científico publicado en 2017

Isavuconazole susceptibility of clinical Aspergillus fumigatus isolates and feasibility of isavuconazole dose escalation to treat isolates with elevated MICs.

artículo científico publicado en 2017

Moderate correlation between systemic IL-6 responses and CRP with trough concentrations of voriconazole

article

Pharmacodynamics of isavuconazole in an Aspergillus fumigatus mouse infection model

artículo científico publicado en 2015

Pharmacokinetic Properties of Micafungin in Critically Ill Patients Diagnosed with Invasive Candidiasis.

artículo científico publicado en 2017

Pharmacokinetics and Pharmacodynamics of Posaconazole

scientific article published on 22 April 2020

Pharmacokinetics of Anidulafungin in Obese and Normal-Weight Adults.

artículo científico publicado en 2018

Population pharmacokinetics of vancomycin in obesity: Finding the optimal dose for (morbidly) obese individuals

scientific article published on 07 January 2020

Prospective validation of a model-informed precision dosing tool for vancomycin in intensive care patients

artículo científico publicado en 2020

Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion

artículo científico publicado en 2020

Screening of the central nervous system in children with invasive pulmonary aspergillosis.

artículo científico publicado en 2014

Therapeutic drug monitoring of voriconazole.

artículo científico publicado en 2008

Lista de obras de

A Multidisciplinary Approach to Fungal Infections: One-Year Experiences of a Center of Expertise in Mycology

Cyclosporine A trough concentrations are associated with acute GvHD after non-myeloablative allogeneic hematopoietic cell transplantation

Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance

Drug-interactions of azole antifungals with selected immunosuppressants in transplant patients: strategies for optimal management in clinical practice

Favorable outcome of neonatal cerebrospinal fluid shunt-associated Candida meningitis with caspofungin.

Flucloxacillin Results in Suboptimal Plasma Voriconazole Concentrations.

Impact of therapeutic drug monitoring of voriconazole in a pediatric population

Implications for IV posaconazole dosing in the era of obesity

In reply to comment on ‘Therapeutic drug monitoring-guided treatment versus standard dosing of voriconazole for invasive aspergillosis in haematological patients: A multicentre, prospective, cluster randomised, crossover clinical trial’

International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus.

Isavuconazole susceptibility of clinical Aspergillus fumigatus isolates and feasibility of isavuconazole dose escalation to treat isolates with elevated MICs.

Isavuconazole susceptibility of clinical Aspergillus fumigatus isolates and feasibility of isavuconazole dose escalation to treat isolates with elevated MICs.

Moderate correlation between systemic IL-6 responses and CRP with trough concentrations of voriconazole

Pharmacodynamics of isavuconazole in an Aspergillus fumigatus mouse infection model

Pharmacokinetic Properties of Micafungin in Critically Ill Patients Diagnosed with Invasive Candidiasis.

Pharmacokinetics and Pharmacodynamics of Posaconazole

Pharmacokinetics of Anidulafungin in Obese and Normal-Weight Adults.

Population pharmacokinetics of vancomycin in obesity: Finding the optimal dose for (morbidly) obese individuals

Prospective validation of a model-informed precision dosing tool for vancomycin in intensive care patients

Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion

Screening of the central nervous system in children with invasive pulmonary aspergillosis.

Therapeutic drug monitoring of voriconazole.